Risk factors for long-term persistence of serum hepatitis B surface antigen following acute hepatitis B virus infection in Japanese adults

Hepatology

Volumn 59, Issue 1, 2014, Pages 89-97

  Ito, Kiyoaki ^a,m   Yotsuyanagi, Hiroshi ^b   Yatsuhashi, Hiroshi ^c   Karino, Yoshiyasu ^d   Takikawa, Yasuhiro ^e   Saito, Takafumi ^f   Arase, Yasuji ^g   Imazeki, Fumio ^h   Kurosaki, Masayuki ⁱ   Umemura, Takeji ^j   Ichida, Takafumi ^k   Toyoda, Hidenori ^l   Yoneda, Masashi ^m   Mita, Eiji ⁿ   Yamamoto, Kazuhide ^o   Michitaka, Kojiro ^p   Maeshiro, Tatsuji ^q   Tanuma, Junko ^a   Tanaka, Yasuhito ^r   Sugiyama, Masaya ^a   Murata, Kazumoto ^a   Masaki, Naohiko ^a   Mizokami, Masashi ^a   Imai, Yasuharu ^s   Yamada, Norie ^t   Takahashi, Hideaki ^t   Ishii, Koji ^u   Nomura, Hideyuki ^u   Nishida, Jiro ^v   Mikami, Shigeru ^w   Kitamura, Tsuneo ^x   Tsubota, Akihito ^y   Shimada, Noritomo ^z   Ishikawa, Tetsuya ^aa   Ueno, Yoshiyuki ^ab   Ohno, Tomoyoshi ^ac   Orito, Etsuro ^ad   Suzuki, Michihiro ^ae   Takagi, Hitoshi ^af   Tomita, Eiichi ^ag   Takashi, Kumada ^l   Mizuta, Toshihiko ^ah   Mine, Tetsuya ^ai   Kang, Jong Hon ^aj   Hirano, Katsuji ^k   Tsubouchi, Hirohito ^ak   Nozaki, Akito ^al   Sakai, Akito ^am   Nishiguchi, Shuhei ^an   Tamori, Akihiro ^ao   Hagiwara, Satoru ^ap   Nakazawa, Takahide ^aq   Sata, Michio ^ar   Kamoshida, Toshiro ^as   Takahashi, Atsushi ^at   Kakizaki, Satoshi ^af   Kobayashi, Yoshimasa ^au   Sasaki, Shigeru ^av   Ikegami, Tadashi ^aw   Hiasa, Yoichi ^p   Nagata, Kenji ^ax   Kubota, Tomoyuki ^ay   Mitsui, Hiroshi ^az   Yamamoto, Norihiko ^ba   Tsuge, Masataka ^bb   Sato, Shuichi ^bc   Ito, Yoshito ^bd   Sato, Wataru ^be   Uchida, Shigeharu ^bf   Tada, Yuki ^bg   Mizuochi, Toshiaki ^bg   Furusho, Norihiro ^bh   Hige, Shuhei ^bi   more..

^a NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c NATIONAL HOSPITAL ORGANIZATION NAGASAKI MEDICAL CENTER   (Japan)

^d Sapporo Kosei General Hospital   (Japan)

^e IWATE MEDICAL UNIVERSITY   (Japan)

^f YAMAGATA UNIVERSITY   (Japan)

^g TORANOMON HOSPITAL   (Japan)

^h CHIBA UNIVERSITY   (Japan)

ⁱ MUSASHINO RED CROSS HOSPITAL   (Japan)

^j SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^k JUNTENDO UNIVERSITY SHIZUOKA HOSPITAL   (Japan)

^l OGAKI MUNICIPAL HOSPITAL   (Japan)

^m AICHI MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

ⁿ OSAKA NATIONAL HOSPITAL   (Japan)

^o OKAYAMA UNIVERSITY   (Japan)

^p EHIME UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^q UNIVERSITY OF THE RYUKYUS   (Japan)

^r NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

^s Ikeda Municipal Hospital   (Japan)

^t ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^u TOHO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^v TOKYO DENTAL COLLEGE   (Japan)

^w Department of Medicine   (Japan)

^x JUNTENDO UNIVERSITY URAYASU HOSPITAL   (Japan)

^y JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^z Shinmatsudo Central General Hospital   (Japan)

^aa NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^ab TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^ac CHUKYO HOSPITAL   (Japan)

^ad NAGOYA DAINI RED CROSS HOSPITAL   (Japan)

^ae KAWASAKI MUNICIPAL TAMA HOSPITAL   (Japan)

^af GUNMA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^ag Gifu Municipal Hospital   (Japan)

^ah SAGA UNIVERSITY   (Japan)

^ai TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^aj TEINE KEIJINKAI HOSPITAL   (Japan)

^ak KAGOSHIMA UNIVERSITY   (Japan)

^al YOKOHAMA CITY UNIVERSITY MEDICAL CENTER   (Japan)

^am KANAZAWA UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCE   (Japan)

^an HYOGO COLLEGE OF MEDICINE   (Japan)

^ao OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^ap KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^aq KITASATO UNIVERSITY HOSPITAL   (Japan)

^ar KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^as Hitachi   (Japan)

^at FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

^au HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^av SAPPORO MEDICAL UNIVERSITY   (Japan)

^aw TOKYO MEDICAL UNIVERSITY   (Japan)

^ax UNIVERSITY OF MIYAZAKI   (Japan)

^ay Saiseikai Niigata Daini Hospital   (Japan)

^az TOKYO TEISHIN HOSPITAL   (Japan)

^ba MIE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^bb HIROSHIMA UNIVERSITY   (Japan)

^bc SHIMANE UNIVERSITY HOSPITAL   (Japan)

^bd KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^be AKITA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^bf SUWA RED CROSS HOSPITAL   (Japan)

^bg NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^bh KYUSHU UNIVERSITY   (Japan)

^bi HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ENTECAVIR; HEPATITIS B SURFACE ANTIGEN; LAMIVUDINE; NUCLEOTIDE DERIVATIVE; VIRUS DNA; ANTIVIRUS AGENT; GUANINE; DRUG DERIVATIVE;

ACUTE HEPATITIS B; ADULT; ARTICLE; CHRONICITY; CONTROLLED STUDY; DISEASE COURSE; FEMALE; FOLLOW UP; GENOTYPE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; JAPANESE (PEOPLE); MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MIXED INFECTION; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RISK FACTOR; VIRAL CLEARANCE; YOUNG ADULT; ANALOGS AND DERIVATIVES; BLOOD; CLINICAL TRIAL; COHORT ANALYSIS; COMPARATIVE STUDY; GENETICS; HEPATITIS B; HEPATITIS B VIRUS; JAPAN; MULTICENTER STUDY; TIME; VIROLOGY;

ADULT; ANTIVIRAL AGENTS; COHORT STUDIES; DISEASE PROGRESSION; FEMALE; GENOTYPE; GUANINE; HEPATITIS B; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HUMANS; JAPAN; LAMIVUDINE; MALE; MIDDLE AGED; RISK FACTORS; TIME FACTORS; YOUNG ADULT;

EID: 84894849675     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.26635     Document Type: Article

References (37)

1. Mast EE, Alter MJ, Margolis HS. Strategies to prevent and control hepatitis B and C virus infections: a global perspective. Vaccine 1999;17:1730-1733.
2. Lavanchy D. Worldwide epidemiology of HBV infection, disease burden, and vaccine prevention. J Clin Virol 2005;34(Suppl 1):S1-S3.
3. Okamoto H, Tsuda F, Sakugawa H, Sastrosoewignjo RI, Imai M, Miyakawa Y, et al. Typing hepatitis B virus by homology in nucleotide sequence: comparison of surface antigen subtypes. J Gen Virol 1988;69(Pt 10):2575-2583.
4. Norder H, Hammas B, Lofdahl S, Courouce AM, Magnius LO. Comparison of the amino acid sequences of nine different serotypes of hepatitis B surface antigen and genomic classification of the corresponding hepatitis B virus strains. J Gen Virol 1992;73(Pt 5):1201-1208.
5. Miyakawa Y, Mizokami M. Classifying hepatitis B virus genotypes. Intervirology 2003;46:329-338.
6. Fung SK, Lok AS. Hepatitis B virus genotypes: do they play a role in the outcome of HBV infection? Hepatology 2004;40:790-792.
7. Norder H, Courouce AM, Coursaget P, Echevarria JM, Lee SD, Mushahwar IK, et al. Genetic diversity of hepatitis B virus strains derived worldwide: genotypes, subgenotypes, and HBsAg subtypes. Intervirology 2004;47:289-309.
8. Kurbanov F, Tanaka Y, Mizokami M. Geographical and genetic diversity of the human hepatitis B virus. Hepatol Res;40:14-30.
9. Kao JH. Hepatitis B viral genotypes: clinical relevance and molecular characteristics. J Gastroenterol Hepatol 2002;17:643-650.
10. Orito E, Ichida T, Sakugawa H, Sata M, Horiike N, Hino K, et al. Geographic distribution of hepatitis B virus (HBV) genotype in patients with chronic HBV infection in Japan. Hepatology 2001;34:590-594.
11. Matsuura K, Tanaka Y, Hige S, Yamada G, Murawaki Y, Komatsu M, et al. Distribution of hepatitis B virus genotypes among patients with chronic infection in Japan shifting toward an increase of genotype A. J Clin Microbiol 2009;47:1476-1483.
12. Ozasa A, Tanaka Y, Orito E, Sugiyama M, Kang JH, Hige S, et al. Influence of genotypes and precore mutations on fulminant or chronic outcome of acute hepatitis B virus infection. Hepatology 2006;44:326-334.
13. Kobayashi M, Ikeda K, Arase Y, Suzuki F, Akuta N, Hosaka T, et al. Change of hepatitis B virus genotypes in acute and chronic infections in Japan. J Med Virol 2008;80:1880-1884.
14. Mayerat C, Mantegani A, Frei PC. Does hepatitis B virus (HBV) genotype influence the clinical outcome of HBV infection? J Viral Hepat 1999;6:299-304.
15. Ogawa M, Hasegawa K, Naritomi T, Torii N, Hayashi N. Clinical features and viral sequences of various genotypes of hepatitis B virus compared among patients with acute hepatitis B. Hepatol Res 2002;23:167-177.
16. Gilson RJ, Hawkins AE, Beecham MR, Ross E, Waite J, Briggs M, et al. Interactions between HIV and hepatitis B virus in homosexual men: effects on the natural history of infection. AIDS 1997;11:597-606.
17. Usuda S, Okamoto H, Iwanari H, Baba K, Tsuda F, Miyakawa Y, et al. Serological detection of hepatitis B virus genotypes by ELISA with monoclonal antibodies to type-specific epitopes in the preS2-region product. J Virol Methods 1999;80:97-112.
18. Usuda S, Okamoto H, Tanaka T, Kidd-Ljunggren K, Holland PV, Miyakawa Y, et al. Differentiation of hepatitis B virus genotypes D and E by ELISA using monoclonal antibodies to epitopes on the preS2-region product. J Virol Methods 2000;87:81-89.
19. Noto H, Terao T, Ryou S, Hirose Y, Yoshida T, Ookubo H, et al. Combined passive and active immunoprophylaxis for preventing perinatal transmission of the hepatitis B virus carrier state in Shizuoka, Japan during 1980-1994. J Gastroenterol Hepatol 2003;18:943-949.
20. Yoshikawa A, Suzuki K, Abe A, Tanaka T, Yamaguchi K, Ishikawa Y, et al. Effect of selective vaccination on a decrease in the rate of hepatitis B virus-positive Japanese first-time blood donors. Transfus Med 2009;19:172-179.
21. Lok AS, McMahon BJ. Chronic hepatitis B. Hepatology 2007;45:507-539.
22. Sato S, Ohhashi W, Ihara H, Sakaya S, Kato T, Ikeda H. Comparison of the sensitivity of NAT using pooled donor samples for HBV and that of a serologic HBsAg assay. Transfusion 2001;41:1107-1113.
23. Sherlock SDJ, editor. Virus hepatitis. London: Blackwell Scientific; 1997.
24. Tassopoulos NC, Papaevangelou GJ, Sjogren MH, Roumeliotou-Karayannis A, Gerin JL, Purcell RH. Natural history of acute hepatitis B surface antigen-positive hepatitis in Greek adults. Gastroenterology 1987;92:1844-1850.
25. McMahon BJ, Alward WL, Hall DB, Heyward WL, Bender TR, Francis DP, et al. Acute hepatitis B virus infection: relation of age to the clinical expression of disease and subsequent development of the carrier state. J Infect Dis 1985;151:599-603.
26. Kao JH, Chen DS. Global control of hepatitis B virus infection. Lancet Infect Dis 2002;2:395-403.
27. Chu CJ, Keeffe EB, Han SH, Perrillo RP, Min AD, Soldevila-Pico C, et al. Hepatitis B virus genotypes in the United States: results of a nationwide study. Gastroenterology 2003;125:444-451.
28. Livingston SE, Simonetti JP, Bulkow LR, Homan CE, Snoweball MM, Cagle HH, et al. Clearance of hepatitis B e antigen in patients with chronic hepatitis B and genotypes A, B, C, D, and F. Gastroenterology. 2007;133:1452-7.
29. Colin JF, Cazals-Hatem D, Loriot MA, Martinot-Peignoux M, Pham BN, Auperin A, et al. Influence of human immunodeficiency virus infection on chronic hepatitis B in homosexual men. Hepatology 1999;29:1306-1310.
30. Bocharov G, Ludewig B, Bertoletti A, Klenerman P, Junt T, Krebs P, et al. Underwhelming the immune response: effect of slow virus growth on CD8+-T-lymphocyte responses. J Virol 2004;78:2247-2254.
31. Sugiyama M, Tanaka Y, Kato T, Orito E, Ito K, Acharya SK, et al. Influence of hepatitis B virus genotypes on the intra- and extracellular expression of viral DNA and antigens. Hepatology 2006;44:915-924.
32. Ito K, Kim KH, Lok AS, Tong S. Characterization of genotype-specific carboxyl-terminal cleavage sites of hepatitis B virus e antigen precursor and identification of furin as the candidate enzyme. J Virol 2009;83:3507-3517.
33. Milich D, Liang TJ. Exploring the biological basis of hepatitis B e antigen in hepatitis B virus infection. Hepatology 2003;38:1075-1086.
34. Lisotti A, Azzaroli F, Buonfiglioli F, Montagnani M, Alessandrelli F, Mazzella G. Lamivudine treatment for severe acute HBV hepatitis. Int J Med Sci 2008;5:309-312.
35. Jochum C, Gieseler RK, Gawlista I, Fiedler A, Manka P, Saner FH, et al. Hepatitis B-associated acute liver failure: immediate treatment with entecavir inhibits hepatitis B virus replication and potentially its sequelae. Digestion 2009;80:235-240.
36. Yu JW, Sun LJ, Zhao YH, Kang P, Li SC. The study of efficacy of lamivudine in patients with severe acute hepatitis B. Dig Dis Sci 2010;55:775-783.
37. Kumar M, Satapathy S, Monga R, Das K, Hissar S, Pande C, et al. A randomized controlled trial of lamivudine to treat acute hepatitis B. Hepatology 2007;45:97-101.